CA2323809A1 - A method for chemoprevention of prostate cancer - Google Patents
A method for chemoprevention of prostate cancer Download PDFInfo
- Publication number
- CA2323809A1 CA2323809A1 CA002323809A CA2323809A CA2323809A1 CA 2323809 A1 CA2323809 A1 CA 2323809A1 CA 002323809 A CA002323809 A CA 002323809A CA 2323809 A CA2323809 A CA 2323809A CA 2323809 A1 CA2323809 A1 CA 2323809A1
- Authority
- CA
- Canada
- Prior art keywords
- prostate cancer
- prostate
- chemoprevention
- provides
- toremifene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Abstract
This invention provides the chemoprevention of prostate cancer and, more particularly, to a method of administering to a subject an effective dose of a chemopreventive agent, toremifene and analogs or metabolites thereof, to prevent recurrence of, suppress or inhibit prostate carcinogenesis. The present invention provides a safe and effective method for suppressing or inhibiting latent prostate cancer and is particularly useful for treating subjects having an elevated risk of developing prostate cancer, for example, those having benign prostatic hyperplasia, prostate intraepithelial neoplasia (PIN), or an abnormally high level of circulating prostate specific antibody (PSA), or who have a family history of prostate cancer.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8460298P | 1998-05-07 | 1998-05-07 | |
US60/084,602 | 1998-05-07 | ||
PCT/US1999/010146 WO1999056739A1 (en) | 1998-05-07 | 1999-05-07 | A method for chemoprevention of prostate cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2323809A1 true CA2323809A1 (en) | 1999-11-11 |
CA2323809C CA2323809C (en) | 2007-09-18 |
Family
ID=22186034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002323809A Expired - Fee Related CA2323809C (en) | 1998-05-07 | 1999-05-07 | A method for chemoprevention of prostate cancer |
Country Status (26)
Country | Link |
---|---|
US (1) | US6265448B1 (en) |
EP (3) | EP1003496B1 (en) |
JP (2) | JP4482229B2 (en) |
AT (1) | ATE283043T1 (en) |
AU (1) | AU761435B2 (en) |
BG (1) | BG65597B1 (en) |
CA (1) | CA2323809C (en) |
CZ (1) | CZ300960B6 (en) |
DE (2) | DE69922131T2 (en) |
DK (1) | DK1003496T3 (en) |
EA (1) | EA003466B1 (en) |
ES (1) | ES2145730T3 (en) |
HR (1) | HRP20000729A2 (en) |
HU (1) | HUP0102068A3 (en) |
IL (3) | IL138437A0 (en) |
IS (2) | IS2213B (en) |
NO (1) | NO20005625L (en) |
NZ (1) | NZ527522A (en) |
PL (1) | PL207462B1 (en) |
PT (1) | PT1003496E (en) |
SI (1) | SI1003496T1 (en) |
SK (1) | SK16642000A3 (en) |
TR (1) | TR200003269T2 (en) |
UA (1) | UA74532C2 (en) |
WO (1) | WO1999056739A1 (en) |
YU (1) | YU68600A (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ300960B6 (en) * | 1998-05-07 | 2009-09-23 | The University Of Tennessee Research Corporation | Medicament for treating prostate intraepithelial neoplasia |
US6413535B1 (en) * | 1998-05-07 | 2002-07-02 | The University Of Tennessee Research Corporation | Method for chemoprevention of prostate cancer |
US6413533B1 (en) * | 1998-05-07 | 2002-07-02 | The University Of Tennessee Research Corporation | Method for chemoprevention of prostate cancer |
US20030130316A1 (en) * | 2000-03-20 | 2003-07-10 | Steiner Mitchell S. | Method for chemoprevention of prostate cancer |
US20040186185A1 (en) * | 1998-05-07 | 2004-09-23 | Steiner Mitchell S. | Method for treatment and chemoprevention of prostate cancer |
US20040092602A1 (en) * | 1998-05-07 | 2004-05-13 | Steiner Mitchell S. | Method for treatment and chemoprevention of prostate cancer |
US6642274B1 (en) | 1999-09-09 | 2003-11-04 | Gary W. Neal | Methods and compositions for preventing and treating prostate disorders |
AU7360700A (en) * | 1999-09-09 | 2001-04-10 | Androsolutions, Inc. | Methods and compositions for preventing and treating urinary tract disorders |
US20060269611A1 (en) * | 2001-11-29 | 2006-11-30 | Steiner Mitchell S | Prevention and treatment of androgen-deprivation induced osteoporosis |
DK1460969T3 (en) | 2001-11-29 | 2008-09-01 | Gtx Inc | Prevention and treatment of androgen deprivation caused by osteoporosis |
US20050080143A1 (en) * | 2001-11-29 | 2005-04-14 | Steiner Mitchell S. | Treatment of androgen-deprivation induced osteoporosis |
US20040213841A1 (en) * | 2001-11-29 | 2004-10-28 | Steiner Mitchell S | Methods for treating hot flashes and gynecomastia |
US20070197664A1 (en) * | 2001-11-29 | 2007-08-23 | Steiner Mitchell S | Prevention and treatment of androgen-deprivation induced osteoporosis |
US7524866B2 (en) * | 2001-11-29 | 2009-04-28 | Gtx, Inc. | Prevention and treatment of androgen—deprivation induced osteoporosis |
US20040214898A1 (en) * | 2001-11-29 | 2004-10-28 | Steiner Mitchell S. | Methods for treating hot flashes |
US20080249183A1 (en) * | 2001-11-29 | 2008-10-09 | Steiner Mitchell S | Treatment of androgen-deprivation induced osteoporosis |
US20040096510A1 (en) * | 2001-11-29 | 2004-05-20 | Steiner Mitchell S. | Prevention and treatment of androgen-deprivation induced osteoporosis |
US7332525B2 (en) * | 2003-01-17 | 2008-02-19 | Castle Erik P | Method of treatment of prostate cancer and composition for treatment thereof |
US7070816B2 (en) * | 2003-12-05 | 2006-07-04 | New Chapter, Inc. | Methods for treating prostatic intraepithelial neoplasia with herbal compositions |
US20050208159A1 (en) * | 2004-03-16 | 2005-09-22 | Kang Kyung S | Phytoestrogenic composition comprising an extract of chinese licorice root, liquiritin or isoliquiritin |
US20060019989A1 (en) * | 2004-07-21 | 2006-01-26 | Steiner Mitchell S | Compositions comprising 5-alpha reductase inhibitors and SERMs and methods of use thereof |
WO2006052921A2 (en) * | 2004-11-08 | 2006-05-18 | Eastman Chemical Company | Cyclodextrin solubilizers for liquid and semi-solid formulations |
WO2006052922A2 (en) * | 2004-11-08 | 2006-05-18 | Eastman Chemical Company | Pharmaceutical formulations of cyclodextrins and selective estrogen receptor modulator compounds |
US20060270641A1 (en) * | 2005-05-31 | 2006-11-30 | Steiner Mitchell S | Method for chemoprevention of prostate cancer |
USD969722S1 (en) | 2021-09-28 | 2022-11-15 | Wagner Delima | Stabilizing wedge pad |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4329364A (en) | 1974-09-11 | 1982-05-11 | Schering Corporation | Antiandrogenic agents and methods for the treatment of androgen dependent disease states |
US4474813A (en) | 1980-10-24 | 1984-10-02 | Schering Corporation | Pharmaceutical preparations comprising flutamide |
GB2126576B (en) | 1982-06-25 | 1985-06-19 | Farmos Group Limited | Alkane and alkene derivatives |
FI77839C (en) * | 1982-05-27 | 1989-05-10 | Farmos Oy | FOERFARANDE FOER FRAMSTAELLNING AV NYA THERAPEUTIC EFFECTIVE TRIPHENYLALKAN- OCH ALKENDERIVAT. |
US5491173A (en) | 1982-06-25 | 1996-02-13 | Orion-Yhtyma Oy | Tri-phenyl alkene derivatives and their preparation and use |
US5595985A (en) | 1989-03-10 | 1997-01-21 | Endorecherche Inc. | Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
US4990538A (en) | 1989-08-23 | 1991-02-05 | Harris Adrian L | Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs |
GB9126209D0 (en) | 1991-12-10 | 1992-02-12 | Orion Yhtymae Oy | Drug formulations for parenteral use |
GB9207437D0 (en) | 1992-04-03 | 1992-05-20 | Orion Yhtymae Oy | Topical administration of toremifene and its metabolites |
JPH08503848A (en) * | 1992-12-01 | 1996-04-30 | マイヤ ヴェリ、アニ | Syndecan stimulation of cell differentiation |
US5595722A (en) | 1993-01-28 | 1997-01-21 | Neorx Corporation | Method for identifying an agent which increases TGF-beta levels |
ATE406909T1 (en) | 1993-05-13 | 2008-09-15 | Poniard Pharmaceuticals Inc | PREVENTION AND TREATMENT OF PATHOLOGIES ASSOCIATED WITH ABNORMAL PROLIFERATION OF SMOOTH MUSCLE CELLS |
ATE208207T1 (en) | 1993-08-09 | 2001-11-15 | Edward Baral | A METHOD FOR SENSITIZING CANCER CELLS TO KILLER CELL-MEDIATED LYSIS |
US5650425A (en) | 1994-04-04 | 1997-07-22 | Pharmos Corporation | Permanently ionic derivatives of steroid hormones and their antagonists |
US5629007A (en) | 1995-03-21 | 1997-05-13 | Eli Lilly And Company | Method of preventing prostatic cancer development |
US5635197A (en) | 1995-03-21 | 1997-06-03 | Eli Lilly And Company | Treatment and prevention of prostatic cancer metastasis |
ZA984650B (en) * | 1997-06-19 | 1998-12-08 | Orion Corp | Intratumoral administration of triphenylethylenes for the treatment of cancer |
CZ300960B6 (en) * | 1998-05-07 | 2009-09-23 | The University Of Tennessee Research Corporation | Medicament for treating prostate intraepithelial neoplasia |
-
1999
- 1999-05-07 CZ CZ20004118A patent/CZ300960B6/en not_active IP Right Cessation
- 1999-05-07 JP JP2000546766A patent/JP4482229B2/en not_active Expired - Lifetime
- 1999-05-07 CA CA002323809A patent/CA2323809C/en not_active Expired - Fee Related
- 1999-05-07 PT PT99924157T patent/PT1003496E/en unknown
- 1999-05-07 HU HU0102068A patent/HUP0102068A3/en unknown
- 1999-05-07 SK SK1664-2000A patent/SK16642000A3/en unknown
- 1999-05-07 DE DE69922131T patent/DE69922131T2/en not_active Expired - Lifetime
- 1999-05-07 DE DE1003496T patent/DE1003496T1/en active Pending
- 1999-05-07 SI SI9930740T patent/SI1003496T1/en unknown
- 1999-05-07 PL PL344000A patent/PL207462B1/en not_active IP Right Cessation
- 1999-05-07 US US09/306,958 patent/US6265448B1/en not_active Expired - Fee Related
- 1999-05-07 WO PCT/US1999/010146 patent/WO1999056739A1/en active Search and Examination
- 1999-05-07 NZ NZ527522A patent/NZ527522A/en unknown
- 1999-05-07 ES ES99924157T patent/ES2145730T3/en not_active Expired - Lifetime
- 1999-05-07 YU YU68600A patent/YU68600A/en unknown
- 1999-05-07 EP EP99924157A patent/EP1003496B1/en not_active Expired - Lifetime
- 1999-05-07 IL IL13843799A patent/IL138437A0/en unknown
- 1999-05-07 EA EA200000100A patent/EA003466B1/en not_active IP Right Cessation
- 1999-05-07 EP EP04018861A patent/EP1475087A3/en not_active Withdrawn
- 1999-05-07 AT AT99924157T patent/ATE283043T1/en not_active IP Right Cessation
- 1999-05-07 EP EP10012242A patent/EP2277514A1/en not_active Withdrawn
- 1999-05-07 DK DK99924157T patent/DK1003496T3/en active
- 1999-05-07 AU AU40726/99A patent/AU761435B2/en not_active Ceased
- 1999-05-07 TR TR2000/03269T patent/TR200003269T2/en unknown
- 1999-07-05 UA UA2000116229A patent/UA74532C2/en unknown
-
2000
- 2000-09-12 IL IL138437A patent/IL138437A/en not_active IP Right Cessation
- 2000-10-27 HR HR20000729A patent/HRP20000729A2/en not_active Application Discontinuation
- 2000-11-01 IS IS5700A patent/IS2213B/en unknown
- 2000-11-07 NO NO20005625A patent/NO20005625L/en not_active Application Discontinuation
- 2000-12-05 BG BG105022A patent/BG65597B1/en unknown
-
2006
- 2006-03-15 IS IS8354A patent/IS8354A/en unknown
-
2008
- 2008-03-21 JP JP2008074318A patent/JP2008163048A/en active Pending
- 2008-08-04 IL IL193231A patent/IL193231A0/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2323809A1 (en) | A method for chemoprevention of prostate cancer | |
NO20022221L (en) | A procedure for a chemical prevention of prostate cancer | |
Liu et al. | Monoamine metabolism provides an antioxidant defense in the brain against oxidant-and free radical-induced damage | |
EA200000220A1 (en) | COMBINATION OF TYROSINKINASE INHIBITOR AND CHEMICAL STERILIZATION FOR TREATMENT OF PROSTATE GLAND | |
WO2002064163A3 (en) | Reduction or prevention of pdt related inflammation | |
BR9815171A (en) | IV powder inhibiting compound applicable in the treatment of diseases, particularly asthma, in mammals and method for treating a patient suffering from sick conditions. | |
CA2062973A1 (en) | Combination therapy for prophylaxsis and/or treatment of benign prostatic hyperplasia | |
BR9806060A (en) | Compound, pharmaceutical composition and processes to treat a patient suffering from a sick condition, to inhibit factor xa, and to inhibit thrombin formation. | |
NZ285159A (en) | Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene | |
CA2227205A1 (en) | Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles | |
GR3033828T3 (en) | Substituted biphenyl compounds for the treatment of inflammation | |
SI1624878T1 (en) | Use of compositions comprising an estrogenic component for the treatment and prevention of musculoskeletal pain | |
NO950275L (en) | Combination therapy for osteoporosis | |
DK0735877T3 (en) | 6- (2-imidazolinylamino) quinoxaline compounds suitable as alpha-2-adrenoceptor agonists. | |
BR0112364A (en) | Combinations of bisphosphonates, estrogens and optionally estrogens | |
BR9813996A (en) | 2-arylbenzo [b] thiophenes useful for the treatment of estrogen deprivation syndrome | |
DE3364588D1 (en) | Fungicidal agent | |
BR0101161A (en) | Developing composition and heat-sensitive recording material | |
Parkinson et al. | Cytochrome P-450-mediated metabolism of biphenyl and the 4-halobiphenyls | |
DK0986393T3 (en) | Use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer | |
TW325997B (en) | Pharmaceutical composition for preventing and treating retinal diseases | |
Von Burg et al. | Biliary mobilization of cadmium by 2, 3‐dimercaptopropanol and some related compounds | |
WO2000016712A3 (en) | Calcified tissue facing preparation containing an antimicrobial agent | |
CA2440214A1 (en) | Method of modulating the proliferation of medullary thyroid carcinoma cells | |
IL112344A (en) | Pharmaceutical compositions comprising 7, 9, 9-trisubstituted- 3-benzoyl-3, 7-diazabicyclo £3.3.1| nonanes for the treatment of cardiac arrhythmias |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |